Treating Heavy Periods in People with Bleeding Disorders
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
['FUNDING_R01'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-11193531
This project compares two hormone treatments to help young people with bleeding disorders manage heavy periods and improve their quality of life.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON HEALTH & SCIENCE UNIVERSITY (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-11193531 on ClinicalTrials.gov |
What this research studies
Heavy menstrual bleeding is common among adolescents and young adults with a bleeding disorder and can negatively impact their daily life and overall health. While effective treatments exist to lessen bleeding and improve quality of life, they haven't been specifically studied in individuals with bleeding disorders, so we don't know how well they work for this group. This project will involve 300 adolescents and young adults with heavy periods and a diagnosed bleeding disorder who are choosing to start a progestin treatment. We will compare the effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUD) versus daily oral norethindrone acetate (NETA) over six months. The goal is to see which treatment best reduces bleeding, improves quality of life, and helps restore iron levels.
Who could benefit from this research
Good fit: Ideal candidates are adolescents and young adults with heavy menstrual bleeding and a diagnosed heritable bleeding disorder who are considering starting hormonal menstrual suppression.
Not a fit: Patients who do not experience heavy menstrual bleeding or do not have a bleeding disorder would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could provide clear guidance on the most effective hormonal treatments for heavy periods in young people with bleeding disorders, significantly improving their health and daily lives.
How similar studies have performed: While progestin treatments are known to reduce heavy menstrual bleeding, their specific effectiveness and impact on diagnostic testing in individuals with bleeding disorders have not been thoroughly studied.
Where this research is happening
PORTLAND, UNITED STATES
- OREGON HEALTH & SCIENCE UNIVERSITY — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BALDWIN, MAUREEN — OREGON HEALTH & SCIENCE UNIVERSITY
- Study coordinator: BALDWIN, MAUREEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Blood Coagulation Disorders